ANTI-TFPI ANTIBODY BAY 1093884: EARLY TERMINATION OF PHASE II DOSE ESCALATION STUDY DUE TO THROMBOSIS

Ferrante, F; Ingham, S; Kunze, M; Michaels, LA

HAEMOPHILIA, 2020; 26 (): 77